ZYDUSLIFE.NS Profit & Loss

Zydus Lifesciences Ltd.

Profit & Loss · 7 years on file (FY2019-20 to FY2025-26) · fetched 2026-08-24 01:31

Line item	FY2019-20	FY2020-21	FY2021-22	FY2022-23	FY2023-24	FY2024-25	FY2025-26	Source (XBRL element)
Revenue from Operations	₹142.53 Bn	₹151.02 Bn	₹152.65 Bn	₹172.37 Bn	₹195.47 Bn	₹232.41 Bn	₹271.48 Bn	RevenueFromOperations
Gross Revenue (incl. inter-segment)	₹142.53 Bn	₹151.02 Bn	₹152.65 Bn	₹172.37 Bn	₹195.47 Bn	₹232.41 Bn	₹271.48 Bn	SegmentRevenueFromOperations
Other Income	₹1.14 Bn	₹0.37 Bn	₹2.25 Bn	₹1.87 Bn	₹2.84 Bn	₹2.69 Bn	₹5.09 Bn	OtherIncome
Total Income	₹143.67 Bn	₹151.39 Bn	₹154.90 Bn	₹174.24 Bn	₹198.31 Bn	₹235.11 Bn	₹276.58 Bn	Income
Cost of Materials Consumed	₹34.60 Bn	₹38.88 Bn	₹40.43 Bn	₹41.23 Bn	₹45.80 Bn	₹43.73 Bn	₹51.10 Bn	CostOfMaterialsConsumed
Purchases of Stock-in-Trade	₹15.54 Bn	₹14.71 Bn	₹18.65 Bn	₹19.49 Bn	₹18.98 Bn	₹21.50 Bn	₹30.70 Bn	PurchasesOfStockInTrade
Changes in Inventories	₹-0.94 Bn	₹-1.49 Bn	₹-3.62 Bn	₹2.38 Bn	₹-2.50 Bn	₹-1.85 Bn	₹-8.88 Bn	ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade
Employee Benefit Expense	₹24.14 Bn	₹24.90 Bn	₹24.34 Bn	₹27.66 Bn	₹31.38 Bn	₹36.81 Bn	₹44.18 Bn	EmployeeBenefitExpense
Finance Costs	₹3.42 Bn	₹1.64 Bn	₹1.27 Bn	₹1.30 Bn	₹0.81 Bn	₹1.66 Bn	₹4.39 Bn	FinanceCosts
Depreciation and Amortisation	₹6.96 Bn	₹7.25 Bn	₹7.13 Bn	₹7.23 Bn	₹7.64 Bn	₹9.16 Bn	₹14.08 Bn	DepreciationDepletionAndAmortisationExpense
Other Expenses	₹41.35 Bn	₹40.61 Bn	₹39.45 Bn	₹43.02 Bn	₹47.97 Bn	₹61.64 Bn	₹69.63 Bn	OtherExpenses
Total Expenses	₹125.08 Bn	₹126.50 Bn	₹127.64 Bn	₹142.30 Bn	₹150.08 Bn	₹172.65 Bn	₹205.20 Bn	Expenses
Profit Before Exceptional Items and Tax	₹18.59 Bn	₹24.90 Bn	₹27.25 Bn	₹31.94 Bn	₹48.23 Bn	₹62.46 Bn	₹71.38 Bn	ProfitBeforeExceptionalItemsAndTax
Exceptional Items	₹-3.64 Bn	₹-2.05 Bn	₹1.13 Bn	₹-6.04 Bn	₹-0.14 Bn	₹-2.20 Bn	₹-5.17 Bn	ExceptionalItemsBeforeTax
Profit Before Tax	₹14.95 Bn	₹22.85 Bn	₹28.38 Bn	₹25.90 Bn	₹48.09 Bn	₹60.27 Bn	₹66.21 Bn	ProfitBeforeTax
Tax Expense	₹3.20 Bn	₹1.47 Bn	₹5.12 Bn	₹5.88 Bn	₹9.78 Bn	₹14.12 Bn	₹15.95 Bn	TaxExpense
Net Profit (incl. minority interest)	₹12.04 Bn	₹21.85 Bn	₹46.18 Bn	₹20.92 Bn	₹39.73 Bn	₹46.73 Bn	₹51.23 Bn	ProfitLossForPeriod
Net Profit (to shareholders)	₹11.77 Bn	₹21.34 Bn	₹44.87 Bn	₹19.60 Bn	₹1.13 Bn	₹1.47 Bn	₹50.40 Bn	ProfitOrLossAttributableToOwnersOfParent
Basic EPS	₹11.49	₹20.84	₹43.84	₹19.30	₹38.14	₹44.97	₹50.09	BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations
Diluted EPS	₹11.49	₹20.84	₹43.84	₹19.30	₹38.14	₹44.97	₹50.09	DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations

Every figure above is the exact value of the named XBRL element from ZYDUSLIFE.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).